{{unreferenced|date=August 2014}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 470473115
| IUPAC_name = 4-amino-''N''-(6-methoxypyridazin-3-yl)benzenesulfonamide
| image = Sulfamethoxypyridazine.png

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|sulfamethoxypyridazine}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 80-35-3
| ATC_prefix = J01
| ATC_suffix = ED05
| ATC_supplemental =   {{ATCvet|J01|EQ15}}
| PubChem = 5330
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 5139
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = T034E4NS2Z
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D02439
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 102516
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 268869

<!--Chemical data-->
| C=11 | H=12 | N=4 | O=3 | S=1 
| molecular_weight = 280.304 g/mol
| smiles = O=S(=O)(Nc1nnc(OC)cc1)c2ccc(N)cc2
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C11H12N4O3S/c1-18-11-7-6-10(13-14-11)15-19(16,17)9-4-2-8(12)3-5-9/h2-7H,12H2,1H3,(H,13,15)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = VLYWMPOKSSWJAL-UHFFFAOYSA-N
}}

'''Sulfamethoxypyridazine''' is a [[sulfonamide (medicine)|sulfonamide]] [[antibacterial]].

It is prescribed for vaginal irritation, and severe acute thrush.

It is also used in the treatment of [[Dermatitis herpetiformis]], where it is an alternative therapy to [[Dapsone]].

Sulfamethoxypyridazine is supplied as 500mg tablets.



{{Sulfonamides and trimethoprim}}

[[Category:Sulfonamide antibiotics]]
[[Category:Pyridazines]]


{{antibiotic-stub}}